/

Usuario:

1.2.1.3 Libro Científico

Por favor, utilice la liga Insertar nuevo registro para agregar registros, la liga Ver para verificar los datos, si se requiere algún cambio, presione la liga Editar; en caso de querer eliminar toda la información del registro, presione la liga Borrar. Al final presione el botón Aceptar o Confirmar para registrar los cambios

Página anterior Registro anterior Registro siguiente


Nombre del Modulo  1.2.1.3 Libro científico
Titulo  Hello good day http://sextube.in.net/ sextube Bristol-Myers Squibb is conducting late stage trials of itsnext-generation drug, nivolumab, in advanced melanoma, whilerival U.S. drugmaker Merck is developing a competitor,lambrolizumab, which in early-stage
Subtitulo  Hello good day http://sextube.in.net/ sextube Bristol-Myers Squibb is conducting late stage trials of itsnext-generation drug, nivolumab, in advanced melanoma, whilerival U.S. drugmaker Merck is developing a competitor,lambrolizumab, which in early-stage
Colección  Hello good day http://sextube.in.net/ sextube Bristol-Myers Squibb is conducting late stage trials of itsnext-generation drug, nivolumab, in advanced melanoma, whilerival U.S. drugmaker Merck is developing a competitor,lambrolizumab, which in early-stage
Número de Páginas  Hello good day http://sextube.in.net/ sextube Bristol-Myers Squibb is conducting late stage trials of itsnext-generation drug, nivolumab, in advanced melanoma, whilerival U.S. drugmaker Merck is developing a competitor,lambrolizumab, which in early-stage
Edición  Hello good day http://sextube.in.net/ sextube Bristol-Myers Squibb is conducting late stage trials of itsnext-generation drug, nivolumab, in advanced melanoma, whilerival U.S. drugmaker Merck is developing a competitor,lambrolizumab, which in early-stage
ISBN  Hello good day http://sextube.in.net/ sextube Bristol-Myers Squibb is conducting late stage trials of itsnext-generation drug, nivolumab, in advanced melanoma, whilerival U.S. drugmaker Merck is developing a competitor,lambrolizumab, which in early-stage
Pais  Hello good day http://sextube.in.net/ sextube Bristol-Myers Squibb is conducting late stage trials of itsnext-generation drug, nivolumab, in advanced melanoma, whilerival U.S. drugmaker Merck is developing a competitor,lambrolizumab, which in early-stage
Idioma  Hello good day http://sextube.in.net/ sextube Bristol-Myers Squibb is conducting late stage trials of itsnext-generation drug, nivolumab, in advanced melanoma, whilerival U.S. drugmaker Merck is developing a competitor,lambrolizumab, which in early-stage
Editorial  Hello good day http://sextube.in.net/ sextube Bristol-Myers Squibb is conducting late stage trials of itsnext-generation drug, nivolumab, in advanced melanoma, whilerival U.S. drugmaker Merck is developing a competitor,lambrolizumab, which in early-stage
Tiraje  Hello good day http://sextube.in.net/ sextube Bristol-Myers Squibb is conducting late stage trials of itsnext-generation drug, nivolumab, in advanced melanoma, whilerival U.S. drugmaker Merck is developing a competitor,lambrolizumab, which in early-stage
Fecha de Aceptación  0000-00-00
Fecha de Publicación  0000-00-00
Coautores  Hello good day http://sextube.in.net/ sextube Bristol-Myers Squibb is conducting late stage trials of itsnext-generation drug, nivolumab, in advanced melanoma, whilerival U.S. drugmaker Merck is developing a competitor,lambrolizumab, which in early-stage
Año de la Actividad  2013
Observaciones  Hello good day http://sextube.in.net/ sextube Bristol-Myers Squibb is conducting late stage trials of itsnext-generation drug, nivolumab, in advanced melanoma, whilerival U.S. drugmaker Merck is developing a competitor,lambrolizumab, which in early-stage
Proyecto de Investigacion Asignado